AJI Cover
Frequency: Continuous
ISSN: 1553-619X (Print)
ISSN: 1558-3775 (Online)
Research Article Open Access

Polymyositis Initiation Involving Amlodipine Besylate

R. M. Golding1, L. G.F. Giles2 and E. M. Sokoya3
  • 1 The University of New South Wales, Australia
  • 2 University of North Queensland, Australia
  • 3 Baylor College of Medicine, United States

Abstract

Based on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis the evidence suggests that the polymyositis in a particular patient was initiated by taking the drug amlodipine besylate (norvasc). The method of our analysis should serve as a foundation in handling other drug related interactions.

American Journal of Immunology
Volume 2 No. 1, 2006, 19-22

DOI: https://doi.org/10.3844/ajisp.2006.19.22

Submitted On: 1 March 2006 Published On: 31 March 2006

How to Cite: Golding, R. M., Giles, L. G. & Sokoya, E. M. (2006). Polymyositis Initiation Involving Amlodipine Besylate. American Journal of Immunology, 2(1), 19-22. https://doi.org/10.3844/ajisp.2006.19.22

Open AccessCopyright: © 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • 3,800 Views
  • 2,933 Downloads
  • 0 Citations

Download

Keywords

  • Polymyositis
  • blood pressure
  • amlodipine besylate (norvasc)
  • steroid therapy